Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AbbVie Sued by Pension Fund Over $54.5 Billion Shire Deal
Bloomberg
Tuesday, September 16, 2014 - 4:52pm
tags:
AbbVie, Shire, M&A
Amarin Says It Will Complete Cardiovascular Outcomes Trial For Its Fish Oil Pill
Forbes
Tuesday, September 16, 2014 - 2:32pm
tags:
Amarin, fish oil, clinical trials, Vascepa
With FDA confab looming, Chantix experts can't persuade court to unseal Pfizer records
Fierce Pharma
Tuesday, September 16, 2014 - 2:29pm
tags:
FDA, Chantix, smoking cessation, Pfizer
The FDA ‘Revolving Door’ Fosters Conflicts on Advisory Panels
WSJ Pharmalot
Tuesday, September 16, 2014 - 2:21pm
tags:
FDA, advisory panels
Northwest Bio's Cell Therapy Named 'Promising Innovative Medicine'
Drug Discovery and Development
Tuesday, September 16, 2014 - 1:46pm
tags:
Northwest Biotherapeutics, cell therapy, innovation, UK, DCVax-L
Which body parts warrant the biggest biotech venture investments?
Fierce Biotech
Tuesday, September 16, 2014 - 1:44pm
tags:
biotech, venture capital
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Yahoo
Tuesday, September 16, 2014 - 1:42pm
tags:
DeNovo, Eli Lilly, personalized medicine, enzastaurin
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
Tuesday, September 16, 2014 - 1:41pm
tags:
AstraZeneca, Movantik, FDA, opioid-induced constipation, Nektar
Study shows Novo's new diabetes drug effective and safe for children
Yahoo/Reuters
Tuesday, September 16, 2014 - 12:11pm
tags:
Novo Nordisk, diabetes, pediatric, insulin, Tresiba
Merck KGaA agrees to market Lupin drugs in emerging countries
Yahoo/Reuters
Tuesday, September 16, 2014 - 11:58am
tags:
Merck KGaA, Lupin, emerging markets
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
Tuesday, September 16, 2014 - 11:55am
tags:
FDA, AstraZeneca, Nektar, Movantik, opioid-induced constipation
Side effect fears weigh on Merck osteoporosis drug
Pharmaphorum
Tuesday, September 16, 2014 - 10:25am
tags:
Merck, osteoporosis, Odanacatib
Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy
TheStreet.com
Tuesday, September 16, 2014 - 10:18am
tags:
Arena Pharmaceuticals, Belviq, obesity, phentermine
Biodefense drugmaker Siga files for bankruptcy
Yahoo/Reuters
Tuesday, September 16, 2014 - 9:28am
tags:
SIGA technologies, bankruptcy
Allergan Agrees With Bidders on Date of Special Meeting
Bloomberg
Tuesday, September 16, 2014 - 9:26am
tags:
Allergan, Valeant Pharmaceuticals, M&A, Pershing Square
Possible Heart Risk With Testosterone Spurs Debate on Use
Bloomberg
Tuesday, September 16, 2014 - 9:24am
tags:
testosterone, Eli Lilly, Auxilium, Rextoro, Clarus Therapeutics
Lawyer grills DePuy executive over safety studies for Pinnacle hips
Yahoo/Reuters
Tuesday, September 16, 2014 - 9:22am
tags:
JNJ, DePuy, Pinnacle Hip, devices
Lilly to Pay AstraZeneca $500 Million in Alzheimer’s Push
Bloomberg
Tuesday, September 16, 2014 - 9:21am
tags:
Eli Lilly, AstraZeneca, Alzheimer's disease, BACE inhibitors, AZD3293
Xtandi field force to increase by 50% for market-share battle with Zytiga
Fierce Pharma Marketing
Monday, September 15, 2014 - 7:30pm
tags:
Xtandi, Medivation, Astellas, hirings, JNJ, Zytiga
Arena Down On The Back Of Weight-Loss Drug Failure
Bidness Etc.
Monday, September 15, 2014 - 7:28pm
tags:
Arena Pharmaceuticals, obesity, Belviq

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.